# Crispin T. Hiley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/crispin-t-hiley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,880 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 44 |
| i10-index | 69 |
| Last Known Institution | University College London Hospitals NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5035288566 |
| ORCID iD | https://orcid.org/0000-0002-5869-0775 |
| Works | 205 |

## Researcher papers

- [Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade](https://scholariq.org/papers/clonal-neoantigens-elicit-t-cell-immunoreactivity-and-sensitivity-to-immune/)
- [Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution](https://scholariq.org/papers/allele-specific-hla-loss-and-immune-escape-in-lung-cancer-evolution/)
- [Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors](https://scholariq.org/papers/fc-optimized-anti-cd25-depletes-tumor-infiltrating-regulatory-t-cells-and/)
- [Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA](https://scholariq.org/papers/tracking-early-lung-cancer-metastatic-dissemination-in-tracerx-using-ctdna/)
- [The evolution of lung cancer and impact of subclonal selection in TRACERx](https://scholariq.org/papers/the-evolution-of-lung-cancer-and-impact-of-subclonal-selection-in-tracerx/)
- [Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma](https://scholariq.org/papers/determinants-of-anti-pd-1-response-and-resistance-in-clear-cell-renal-cell/)
- [The evolution of non-small cell lung cancer metastases in TRACERx](https://scholariq.org/papers/the-evolution-of-non-small-cell-lung-cancer-metastases-in-tracerx/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [University College London Hospitals NHS Foundation Trust](https://scholariq.org/institutions/university-college-london-hospitals-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.